Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
JUPITER, Fla., April 26, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that it will report its financial results for first quarter 2023 and host a corporate update conference call on Wednesday, May 10, 2023.
Related news for (DYAI)
- Today’s Top Performers: MoBot’s Market Review 07/23/25 07:00 PM
- Breaking News: MoBot’s Latest Update as of 07/23/25 06:00 PM
- Today’s Top Performers: MoBot’s Market Review 07/23/25 05:00 PM
- Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
- Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference